Single-use TFF offers the greatest savings in clinical and contract manufacturing, where the scale is low and changeovers are frequent.
Mark Perreault
Advertisement
Mark Perreault is the director of membrane application development for TangenX technology at Novasep
Articles by Mark Perreault
Advertisement
Latest Updated Articles
An Economic Analysis of Single-Use Tangential Flow Filtration for Biopharmaceutical ApplicationsPublished: November 2nd 2010 | Updated:
Advertisement
Advertisement
Trending on BioPharm International
1
CPHI Frankfurt 2025 Highlights Global Pharma Innovation and Manufacturing Leadership
2
AstraZeneca Lupus Treatment Support in EU Opens Door for Self-Administration Options
3
Applying Analytical Quality by Design Principles to Biopharma Method Development and Optimization
4
Biopharma’s Digital Hopes Versus Actual Implementation
5
